Gadia, Viviano S.
HRN: 23-28-21 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/04/2023
FLUCONAZOLE 150MG (CAP)
07/04/2023
07/06/2023
PO
150mg
OD
Sepsis Secondary To Infected Wound
Waiting Final Action
Indication: Empiric Type of Infection: BloodstreamDisseminated Systemic Infection Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes